Home › Colorectal Cancer › Florida › Clearwater
Colorectal Cancer clinical trials in Clearwater, FL
3 studies for Colorectal Cancer are looking for participants at sites in and around Clearwater (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Morton Plant Hospital, Clearwater
- Mease Countryside Hospital, Safety Harbor · 7 mi away
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Comprehensive Hematology Oncology, Palm Harbor · 8 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Morton Plant Hospital, Clearwater
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Clearwater
- Cardiovascular Disease9 studies
- Lupus8 studies
- Obesity7 studies
- Breast Cancer6 studies
- Heart Failure6 studies
- Non-Small Cell Lung Cancer5 studies
- Psoriatic Arthritis5 studies
- Overweight5 studies
- Coronary Artery Disease5 studies
- Atrial Fibrillation5 studies
- Rheumatoid Arthritis4 studies
- Type 2 Diabetes4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.